Common antipsychotics fuel doubts about safety, efficacy

Share this article:
Common antipsychotics fuel doubts about safety, efficacy
Common antipsychotics fuel doubts about safety, efficacy

Piling onto the concerns about off-label use of antipsychotics, a new study has found four of the most common medications lack safety and effectiveness in older adults.

Researchers at the University of California, San Diego School of Medicine, Stanford University and the University of Iowa examined aripiprazole (Abilify), olanzapine (Zyprexa), quetiapine (Seroquel), and risperidone (Risperdal) in 332 patients over five years. The subjects had diagnoses associated with schizophrenia, mood disorders, post-traumatic stress disorder or dementia. 

The investigators found a third of the patients developed metabolic syndrome within a year, and a fourth developed serious adverse effects after two years.

“While there were a few significant differences among the four drugs, the overall risk-benefit ratio for the AAPs in patients over age 40 was not favorable, irrespective of diagnosis and drug,” said Dilip V. Jeste, M.D., director of the Stein Institute for Research on Aging at UC San Diego. 

There was no placebo in the trial since all the patients had been diagnosed with conditions that required some antipsychotic treatment. The average length of time a patient was on a drug was  generally six months, as the medications had to be halted or switched because they no longer worked or had side effects.

Results were published in The Journal of Clinical Psychiatry on Nov. 27. 


Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.